酸化修飾低密度リポタンパク質の生物活性とその活性抑制因子としてのAsp-hemolysinに関する分子生物学的研究
スポンサーリンク
概要
- 論文の詳細を見る
Oxidatively modified low-density lipoprotein (OxLDL) is present in atherosclerotic lesions and has been proposed to play an important role in atherogenesis. Asp-hemolysin, a hemolytic toxin from Aspergillus fumigatus, is a binding protein for OxLDL. This study was undertaken to clarify the biological activity of OxLDL and the potentially of Asphemolysin as a regulation factor to atherogenic effect by OxLDL. We first analyzed the interaction between OxLDL and blood coagulation factors, which are involved in the blood coagulation pathway. OxLDL caused prolongation of activated partial thromboplastin time (APTT) as a parameter of the intrinsic pathway of blood coagulation in a dose- and oxidation time-dependent manner. In addition, OxLDL significantly inhibited blood coagulation factor VIII, IX, and XI activity. Furthermore, we demonstrated that factor VIII binds to OxLDL. These results indicate that the binding of factor VIII to OxLDL affects the intrinsic pathway of the blood coagulation cascade. Next, to clarify the structure-function relationship of Asp-hemolysin, we expressed Asp-hemolysin in Escherichia coli as a fusion protein with a maltosebinding protein (MBP) and purified it by affinity chromatography. The purified recombinant Asp-hemolysin showed an immunoreactivity with the anti-Asp-hemolysin antibody. In addition, MBP-Asp-hemolysin fusion protein exhibited binding activity to Ox-LDL as did native Asp-hemolysin. Furthermore, to investigate the effect of the Asp-hemolysin-related peptide (P-21), a synthetic peptide derived from a region of Asp-hemolysin that is rich in positive charges, on macrophage proliferation induced by OxLDL. P-21 inhibited OxLDL-induced macrophage proliferation in a dose-dependent manner. In addition, the binding analysis of P-21 to OxLDL indicated that P-21 binds to OxLDL. These results indicate that P-21 inhibits the OxLDL-induced macrophage proliferation through binding of P-21 to OxLDL. In conclusion, we have shown that OxLDL affects the intrinsic pathway of blood coagulation, and its mechanism is dependent on the binding of factor VIII to OxLDL. Furthermore, we indicate the possibility that Asp-hemolysin is a useful tool to investigate the pathophysiological significance of OxLDL. In particular, since the P-21, an Asp-hemolysin-related peptide, inhibits the OxLDL-induced macrophage proliferation through binding of P-21 to OxLDL, further study on the binding mechanism between Asp-hemolysin-related peptide and OxLDL may provide important information on the prevention and treatment of atherosclerosis.
- 公益社団法人日本薬学会の論文
- 2006-10-01
著者
関連論文
- 吸着剤による室内空気汚染物質ホルムアルデヒドの除去効果を測定するための新しいデシケータ装置の開発
- マクロファージからのリポポリサッカライド誘導NO産生に対するAsp-hemolysin関連合成ペプチドP-21の影響
- 数種の内分泌攪乱化学物質のマウス腹腔マクロファージ細胞機能に及ぼす影響
- ELISA 法を用いたAsp-homolysinと酸化修飾低密度リポタンパク質の結合解析
- Asp-hemolysinのマクロファージ細胞毒性に対する低密度リポタンパク質及びその酸化修飾体の影響
- 血管内皮細胞に対するAsp-hemolysinの細胞毒性とサイトカイン遺伝子発現誘導活性
- Asp-hemolysin の血管透過性亢進作用
- マクロファージに対するAsp-hemolysinの細胞毒性とサイトカイニン遺伝子発現誘導活性
- Aspergillus fumigatus 由来の Asp-hemolysin の生理活性と病原性因子としての意義
- Asp-hemolysinの大腸菌における発現
- 各種培地におけるAspergillus属菌株からのAsp-hemolysinの検出
- Aspergillus fumigatus臨床分離株からのAsp-hemolysinの検出
- Asp-Hemolysin cDNA部分塩基配列の解析
- 酸化修飾低密度リポタンパク質の生物活性とその活性抑制因子としてのAsp-hemolysinに関する分子生物学的研究
- 日-P1-002 CYP2D6活性阻害評価系の構築と健康食品の使用実態調査に基づいた薬物相互作用の解析(健康食品・サプリメント,ポスター発表,一般演題,再興、再考、創ろう最高の医療の未来)